Clinical trial
Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide…
NCT00001270 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001270 |
|---|---|
| Title | Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma |
| Official title | Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Neoplasms, Lymphoma, Neoplasm Metastasis, Testicular Neoplasms |
| Intervention type | Drug |
| Interventions | interleukin-1 |
| Enrollment | 85 |
| Start date | Jun 1, 1991 |
| Completion | Mar 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: